TransMedics Group (TMDX) Misses Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
TransMedics Group (TMDX) PT Lowered to $28 at Cowen
February 24, 2022 6:56 AM ESTCowen analyst Joshua Jennings lowered the price target on TransMedics Group (NASDAQ: TMDX) to $28.00 (from $29.00) while maintaining an Outperform rating.
The analyst commented, "TMDX reported 4Q sales of $9.7M, up 27%, vs the $7.5M consensus. It introduced 2022 sales guidance of $49M-$55M, reflecting... More
